• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染性儿童呼吸衰竭的临床特征及危险因素

Clinical profile and risk factors for respiratory failure in children with infection.

作者信息

Wang Yanfei, Huang Limin, Qian Junjie, Deng Kelei, Yang Zihao, Chen Zhenjie, Li Wei, Tan Linhua

机构信息

Department of Surgical ICU, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.

Department of Nephrology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.

出版信息

Biomol Biomed. 2025 Aug 5;25(9):1972-1981. doi: 10.17305/bb.2024.11641.

DOI:10.17305/bb.2024.11641
PMID:39849991
Abstract

Mycoplasma pneumoniae (MP) is a common cause of community-acquired pneumonia (CAP) in children and can lead to severe complications, including respiratory failure. A retrospective analysis of 2084 children diagnosed with CAP and treated in our hospital from January 2022 to January 2023 was conducted. A comprehensive dataset of patient demographics, clinical symptoms, and laboratory findings was initially assembled. Subsequent statistical analyses were carried out to elucidate the clinical characteristics of MP pneumonia (MPP) in children. Additionally, the study identified high-risk factors for respiratory failure in the context of MPP. Among the hospitalized MPP cases, 15.8% progressed to respiratory failure. Statistical analysis identified D-dimer level as a significant risk factor for respiratory failure in children with MPP. A predictive model was developed using D-dimer levels, yielding an area under the curve (AUC) of 0.818 with a cutoff value of 1.015 mg/L. The model demonstrated a sensitivity of 62.4% and a specificity of 91.3%, proving effective in predicting respiratory failure caused by MPP. Respiratory failure remains a critical complication in children with MPP, and D-dimer levels serve as a key predictive risk factor. Vigilant monitoring of coagulation function, particularly D-dimer levels, is essential for the early identification of patients at risk of developing respiratory failure in MPP cases.

摘要

肺炎支原体(MP)是儿童社区获得性肺炎(CAP)的常见病因,可导致包括呼吸衰竭在内的严重并发症。对2022年1月至2023年1月在我院诊断为CAP并接受治疗的2084例儿童进行了回顾性分析。最初收集了患者人口统计学、临床症状和实验室检查结果的综合数据集。随后进行了统计分析,以阐明儿童支原体肺炎(MPP)的临床特征。此外,该研究还确定了MPP背景下呼吸衰竭的高危因素。在住院的MPP病例中,15.8%进展为呼吸衰竭。统计分析确定D-二聚体水平是MPP患儿呼吸衰竭的一个重要危险因素。利用D-二聚体水平建立了一个预测模型,曲线下面积(AUC)为0.818,临界值为1.015mg/L。该模型的敏感性为62.4%,特异性为91.3%,在预测MPP引起的呼吸衰竭方面证明是有效的。呼吸衰竭仍然是MPP患儿的一种关键并发症,D-二聚体水平是一个关键的预测危险因素。密切监测凝血功能,尤其是D-二聚体水平,对于早期识别MPP病例中有发生呼吸衰竭风险的患者至关重要。

相似文献

1
Clinical profile and risk factors for respiratory failure in children with infection.感染性儿童呼吸衰竭的临床特征及危险因素
Biomol Biomed. 2025 Aug 5;25(9):1972-1981. doi: 10.17305/bb.2024.11641.
2
The predictive value of MUC5AC levels in the sputum of children with pneumonia treated with fiberbronchoscopy.纤维支气管镜治疗的肺炎患儿痰液中MUC5AC水平的预测价值
Microbiol Spectr. 2025 Jul 2:e0010325. doi: 10.1128/spectrum.00103-25.
3
Volume ratio of pulmonary lesions as a novel indicator for predicting the occurrence of plastic bronchitis in children with Mycoplasma pneumoniae pneumonia.肺部病变体积比作为预测支原体肺炎患儿发生塑型性支气管炎的新指标。
Eur J Pediatr. 2025 Jun 9;184(7):409. doi: 10.1007/s00431-025-06251-0.
4
Assessment of serum parameters caused by the outbreak of mycoplasma pneumoniae pneumonia in children after COVID-19.新冠疫情后儿童支原体肺炎爆发所致血清参数评估
Sci Rep. 2025 Aug 3;15(1):28306. doi: 10.1038/s41598-025-13555-6.
5
Pulmonary Embolism in Children With Mycoplasma Pneumoniae Pneumonia: Assessment of Risk Factors and Current Prediction Criteria.支原体肺炎患儿的肺栓塞:危险因素评估及当前预测标准
Pediatr Pulmonol. 2025 Jul;60(7):e71149. doi: 10.1002/ppul.71149.
6
A comparison of diagnostic and therapeutic approaches for Mycoplasma pneumoniae pneumonia in children and adults, during the post-COVID-19 pandemic era.新冠疫情后时代儿童和成人肺炎支原体肺炎的诊断与治疗方法比较
Eur J Clin Microbiol Infect Dis. 2025 Apr 29. doi: 10.1007/s10096-025-05142-4.
7
Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia.儿童和青少年社区获得性肺炎中肺炎支原体诊断的临床症状和体征
Cochrane Database Syst Rev. 2012 Oct 17;10(10):CD009175. doi: 10.1002/14651858.CD009175.pub2.
8
[Risk factors for bronchiolitis obliterans after bronchiolitis in children].[儿童支气管炎后闭塞性细支气管炎的危险因素]
Zhonghua Er Ke Za Zhi. 2025 Jul 2;63(7):772-777. doi: 10.3760/cma.j.cn112140-20250228-00158.
9
Exploration of the Therapeutic Efficacy of Azithromycin Sequential Therapy in Children With Mycoplasma Pneumonia.阿奇霉素序贯疗法治疗儿童支原体肺炎的疗效探讨
Br J Hosp Med (Lond). 2025 Jun 25;86(6):1-18. doi: 10.12968/hmed.2025.0005. Epub 2025 Jun 13.
10
Development and validation of a machine learning model for predicting co-infection of in pediatric patients.用于预测儿科患者合并感染的机器学习模型的开发与验证。
Transl Pediatr. 2025 Jun 27;14(6):1201-1212. doi: 10.21037/tp-2024-562. Epub 2025 Jun 25.